Stents Bioresorbable

This channel includes news and new technology innovations for bioresorbable stents (BRS). These devices are also referred to as bioabsorbable stents, bioresorbable scaffolds and dissolving stents. BRS are designed as an alternative to permanent metallic stent implants, which cause issues in a small number of patients with in-stent restenosis, late-stent thrombosis and require use of long-term antiplatelet therapy. Metallic stents also cause issues with CT and MRI imaging and may prevent future options for coronary bypass graft (CABG) surgery. BRS are supposed to remove avoid these issues by dissolving and disappearing from the vessel after a period of 2-4 years. This, returns the vessel to its natural state and allows for the return of vasodilatation and vasoconstriction. BRS have had some issues in clinical trials not being able to match the performance of standard metallic drug eluting stents (DES) because of their thick stent struts. Newer generation BRS are in development with struts smaller than 100 micros, with will be closer to those of current generation metallic stents

 

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent
Feature | Stents Bioresorbable | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers ...

Home January 17, 2017
Home
News | Stents

January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...

Home January 13, 2017
Home
Absorb, bioresorbable stent, BVS, top cardiology story of 2016
Feature | Dave Fornell

The Diagnostic and Interventional Cardiology (DAIC) website had a record year in 2016, breaking 1 million page views for ...

Home December 21, 2016
Home
News | Stents

November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...

Home November 09, 2016
Home
Videos | Stents Bioresorbable

Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...

Home November 09, 2016
Home
News | Stents

November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...

Home November 07, 2016
Home
News | Stents Bioresorbable

November 7, 2016 — The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 3 ...

Home November 07, 2016
Home
News | Stents

October 28, 2016 — Svelte Medical Systems Inc. announced this week it received CE Mark certification of the Direct ...

Home October 28, 2016
Home
bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT
Feature | Stents Bioresorbable | Dave Fornell

There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular ...

Home October 20, 2016
Home
TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab

September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first report ...

Home September 28, 2016
Home
Blog | Stents Bioresorbable

There was an explosion of interest in bioresorbable stents immediately following the July 5, 2016 announcement that the ...

Home August 16, 2016
Home
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC
Feature | Dave Fornell

 


August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology ...

Home August 05, 2016
Home
News | Stents Bioresorbable

July 26, 2016 — On July 20, Massoud Leesar, M.D., of University of Alabama at Birmingham Hospital implanted a patient ...

Home July 26, 2016
Home
bioresorbable stent, bioabsorbable stent, Absorb BVS, visualizing bioresorbable stents
Feature | Stents Bioresorbable | Alphonse Ambrosia, D.O.

Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of ...

Home July 21, 2016
Home
News | Stents Bioresorbable

July 19, 2016 — Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with ...

Home July 19, 2016
Home
Subscribe Now